[HTML][HTML] Targeting calcium homeostasis in myocardial ischemia/reperfusion injury: an overview of regulatory mechanisms and therapeutic reagents
R Wang, M Wang, S He, G Sun, X Sun - Frontiers in pharmacology, 2020 - frontiersin.org
Calcium homeostasis plays an essential role in maintaining excitation–contraction coupling
(ECC) in cardiomyocytes, including calcium release, recapture, and storage. Disruption of …
(ECC) in cardiomyocytes, including calcium release, recapture, and storage. Disruption of …
Calcium signaling in cardiomyocyte function
G Gilbert, K Demydenko, E Dries… - Cold Spring …, 2020 - cshperspectives.cshlp.org
Rhythmic increases in intracellular Ca2+ concentration underlie the contractile function of
the heart. These heart muscle-wide changes in intracellular Ca2+ are induced and …
the heart. These heart muscle-wide changes in intracellular Ca2+ are induced and …
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European …
G Tarone, JL Balligand, J Bauersachs… - European journal of …, 2014 - Wiley Online Library
The failing heart is characterized by complex tissue remodelling involving increased
cardiomyocyte death, and impairment of sarcomere function, metabolic activity, endothelial …
cardiomyocyte death, and impairment of sarcomere function, metabolic activity, endothelial …
Cardiovascular gene therapy for myocardial infarction
MC Scimia, AM Gumpert, WJ Koch - Expert opinion on biological …, 2014 - Taylor & Francis
Introduction: Cardiovascular gene therapy is the third most popular application for gene
therapy, representing 8.4% of all gene therapy trials as reported in 2012 estimates. Gene …
therapy, representing 8.4% of all gene therapy trials as reported in 2012 estimates. Gene …
[HTML][HTML] Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function
A Traister, M Li, S Aafaqi, M Lu, S Arab… - Nature …, 2014 - nature.com
Human dilated cardiomyopathy (DCM) manifests as a profound reduction in biventricular
cardiac function that typically progresses to death or cardiac transplantation. There is no …
cardiac function that typically progresses to death or cardiac transplantation. There is no …
Myofilament-based physiological regulatory compensation preserves diastolic function in failing hearts with severe Ca2+ handling deficits
FI Heinis, BR Thompson, R Gulati, M Wheelwright… - JCI …, 2024 - Am Soc Clin Investig
Myofilament-based physiological regulatory compensation preserves diastolic function in
failing hearts with severe Ca 2+ handlin Page 1 Myofilament-based physiological regulatory …
failing hearts with severe Ca 2+ handlin Page 1 Myofilament-based physiological regulatory …
[HTML][HTML] A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum
T Größl, E Hammer, S Bien-Möller, A Geisler, S Pinkert… - PloS one, 2014 - journals.plos.org
In failing rat hearts, post-transcriptonal inhibition of phospholamban (PLB) expression by
AAV9 vector-mediated cardiac delivery of short hairpin RNAs directed against PLB (shPLBr) …
AAV9 vector-mediated cardiac delivery of short hairpin RNAs directed against PLB (shPLBr) …
Differential effects of S100 proteins A2 and A6 on cardiac Ca2+ cycling and contractile performance
W Wang, ML Asp, G Guerrero-Serna… - Journal of molecular and …, 2014 - Elsevier
Abstract Defective intracellular calcium (Ca 2+) handling is implicated in the pathogenesis of
heart failure. Novel approaches targeting both cardiac Ca 2+ release and reuptake …
heart failure. Novel approaches targeting both cardiac Ca 2+ release and reuptake …
Gene Transfer for Clinical Congestive Heart Failure
T Tang, HK Hammond - Translating Gene Therapy to the Clinic, 2015 - Elsevier
Congestive heart failure (CHF) is a major cause of morbidity and mortality. Because its
prevalence is increasing and outlook remains dismal despite optimal medical and device …
prevalence is increasing and outlook remains dismal despite optimal medical and device …
Gene transfer for congestive heart failure: update 2013
T Tang, HK Hammond - Translational Research, 2013 - Elsevier
Congestive heart failure is a major cause of morbidity and mortality with increasing social
and economic costs. There have been no new high impact therapeutic agents for this …
and economic costs. There have been no new high impact therapeutic agents for this …